Skip to main content
Fig. 5 | BMC Endocrine Disorders

Fig. 5

From: The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile

Fig. 5

Gastric emptying after 4 (a) and 8 (b) weeks of treatment. Gastric emptying was estimated by the appearance of acetaminophen in plasma 30 min post dosing and calculated as % change relative vehicle. Statistical analysis between groups were performed as a one-way ANONA followed by Tukey’s post-hoc test with the following annotations: **P < 0.01, ***P < 0.001 vs. vehicle and §§§P < 0.001 vs. liraglutide (400 μg/kg). All data are means ± SEM

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us